For Providers
Use the resources below to find evidenced-based guidelines for the prevention, screening, and treatment of cancer in people living with HIV. Use #HIVOnc on twitter to connect with other health professionals and researchers working on HIV malignancies
Cancer screening guidelines for people living with hiv (PLWH)
Legend
NYSDOH AI= New York State Department of Health AIDS Institute, USPSTF= U.S. Preventative Services Task Force, ACOG= American College of Obstetricians and Gynecologists, ASCCP= American Society for Colposcopy and Cervical Pathology, ACS= American Cancer Society, ACG= American College of Gastroenterology, NCCN= National Comprehensive Cancer Network, AASLD= American Association for the Study of Liver Diseases
HPV= Human papilloma virus, gFOBT= Guaiac fecal occult blood test, FIT= Fecal immunochemical test, mtsDNA FIT= Multi-targeted stool DNA fecal immunochemical test, CTC= Computed tomography colonography, HBV= Hepatitis B virus, HCV= Hepatitis C virus, AFP= Alpha-fetoprotein
*Evidence Ratings (grade practice recommendations) vary between source. Please check individual guidelines for description of evidence ratings. Generally, A= Strong recommendation, B= Recommendation, C= Optional, D= Optional
Click the image to the left to view the CDC guidelines for the prevention and treatment of opportunistic infections in PLWH, including HPV, HBV, HCV, and HHV-8 (KSV)
Click the image to the left to view the NCCN guidelines for cancer in PLWH. Please note, you must have an NCCN account to access this file, which is free to create.
Click the image to the left to visit the University of Liverpool's HIV Drug Interactions checker tool. Available in English and Spanish, and as a mobile application from the Apple app store and Google app store. Per NCCN guidelines, HIV medications can be changed if there are concerns for drug-to-drug interactions. Please consult an HIV specialist and/or HIV pharmacist before changing a patient's HIV medications.
References
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Cancer in People with HIV, Version 1.2022. Accessed 02/05/2022.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Breast Cancer Screening and Diagnosis, Version 1.2021. Accessed 02/05/2022.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening, Version 1.2022. Accessed 02/05/2022.
Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at https://clinicalinfo.hiv.gov/en/guidelines/adult- and-adolescent-opportunistic-infection/. Accessed 04/06/2022.
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstet Gynecol. 2017 Jul;130(1):e1-e16. doi: 10.1097/AOG.0000000000002158. PMID: 28644335.
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. PMID: 29624699.
Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 Sep;70(5):321-346. doi: 10.3322/caac.21628. Epub 2020 Jul 30. PMID: 32729638.
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021 Mar 1;116(3):458-479. doi: 10.14309/ajg.0000000000001122. PMID: 33657038.
New York State Department of Health AIDS Institute. (n.d.). Screening for anal dysplasia and cancer in adults with HIV. Retrieved April 12, 2022, from https://www.hivguidelines.org/hiv-care/anal-cancer/
New York State Department of Health AIDS Institute. (n.d.). Screening for cervical dysplasia and cancer in adults with HIV. Retrieved April 12, 2022, from https://www.hivguidelines.org/hiv-care/cervical-cancer
United States Preventive Services Taskforce. (2016, January 11). Breast cancer: Screening. Retrieved April 12, 2022, from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
United States Preventive Services Taskforce. (2018, August 21). Cervical cancer: Screening. Retrieved April 12, 2022, from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
United States Preventive Services Taskforce. (2021, March 9). Lung cancer: Screening. Retrieved April 12, 2022, from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
United States Preventive Services Taskforce. (2021, May 18). Colorectal cancer: Screening. Retrieved April 12, 2022, from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
All data and information provided on www.cancerfreehiv.org comes from peer-reviewed sources. Publications from which data are obtained are listed at the bottom of figures or each page